Claus Andersson has been with the team since inception and focuses on oncology, cardiology and nucleotide modalities.
Claus is actively involved in maintaining our network to life science hubs and start-ups. So far, Claus has been engaged with more than 19 companies and has held either chairing positions or board memberships to share his experience from the last 17 years of working with entrepreneurs, co-investors and consultants in life sciences.
Claus has extensive experience in strategy execution and technology development from various parts of the life science ecosystem: both as an entrepreneur, venture capitalist, scientist, and corporate manager.
Claus holds a master’s degree in Civil Chemical Engineering from the Technical University of Denmark (DTU) and a PhD in Mathematical Statistics from the University of Copenhagen and the Humboldt University in Berlin.
